An Early Phase 1 interventional study of Standard interpersonal psychotherapy (IPT) and Clinician managed interpersonal psychotherapy (CM-IPT) in Depression and Depression, Postpartum, sponsored by University of Iowa. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-09-26.
Sponsored by University of Iowa · Early Phase 1, Interventional, and Treatment
This 12-week study will evaluate the effectiveness of Clinician-Managed Interpersonal Psychotherapy (CM-IPT) in treating postpartum depression and will compare CM-IPT to standard IPT.
CM-IPT is delivered in 12 sessions over the course of a year. Standard IPT is delivered in 12 sessions in the first 12 weeks after treatment assignment.
528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.
This study's enrollment of 140 is above the median of 105 across 425 interventional studies indexed under Depression, Postpartum.
Browse Depression, Postpartum studies →University of Iowa is the lead sponsor of 276 studies on the registry; 35 are open to participants now.
Of its 44 completed or terminated interventional studies of FDA-regulated products, 39 (89%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion criteria:
Participants will receive clinician-managed interpersonal psychotherapy
Behavioral: Clinician managed interpersonal psychotherapy (CM-IPT)
Participants will receive standard interpersonal psychotherapy
Behavioral: Standard interpersonal psychotherapy (IPT)
Participants will receive 12 sessions of IPT over 12 weeks.
Participants will receive 12 sessions of CM-IPT over 1 year.
Hamilton Rating Scale for Depression
Time frame: Measured at Week 12
This study is completed, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Iowa